N01199 1055 — Philadelphia, Pennsylvania

N01199 1055 is a clinical research site located in Philadelphia, Pennsylvania, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

N01199 1055 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB PHARMA Inc. (US).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01199 1055?

N01199 1055 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01199 1055 conducted?

N01199 1055 has 1 clinical trials on record. Their work covers Epilepsy.

Is N01199 1055 accredited by Crixeo Health?

N01199 1055 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01199 1055?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.